International Legal Mechanisms for Counteracting Health Emergencies
- Authors: Malichenko V.1
-
Affiliations:
- The Institute of Legislation and Comparative Law under the Government of the Russian Federation
- Issue: Vol 14, No 1 (2021)
- Pages: 174-197
- Section: Law in the Modern World
- URL: https://journals.rcsi.science/2072-8166/article/view/318099
- DOI: https://doi.org/10.17323/2072-8166.2021.1.174.197
- ID: 318099
Cite item
Full Text
Abstract
About the authors
Vladislav Malichenko
The Institute of Legislation and Comparative Law under the Government of the Russian Federation
Email: noreply@hse.ru
Senior Fellow, Candidate of Juridical Sciences
References
- Branswell H. Who will answer the call in the next outbreak? Drug makers feel burned by string of vaccine pleas. Available at:https://www.statnews.com/2018/01/11/vaccines-drug-makers/(дата обращения: 07.02.2021)
- Evenett S. Sicken thy neighbor: so far 24 nations have limited exports of medical supplies. Global Trade Alert website. Available at:https://www.globaltradealert.org/reports/50(дата обращения: 07.02.2021)
- Baker S., Payne D., Rappuoli R., De Gregorio E. (2018) Technologies to address antimicrobial resistance. Proceedings of the National Academy of Sciences, vol. 115, pp. 12887-12895.
- Bollyky T. et al. (2020) The equitable distribution of COVID-19 therapeutics and vaccines. Journal of the American Medical Association, no 24, pp. 2462-2463.
- Buckley C., Myers S. (2020) China's Old Habits Delayed Fight. New York Times. February 1.
- Drosten C., Günther S., Preiser W. et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England journal of medicine, vol. 348, pp. 1967-1976.
- Eccleston-Turner M., Kamradt-Scott A. (2019) Transparency in IHR emergency committee decision making: the case for reform. British Medical Journal Glob Health, vol. 4, pp. 1-3.
- Fauci A., Morens D. (2012) The perpetual challenge of infectious diseases. New England Journal of Medicine, vol. 366, pp. 454-461.
- Fidler D. (1999) International Law and Infectious Diseases. Oxford: University Press, 416 p.
- Fidler D. (2008) Influenza virus samples, international law, and global health diplomacy. Emerging infectious disease, vol. 14, p. 88-94.
- Fidler D. (2011) Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. Negotiating and Navigating Global Health: Case Studies in Global Health Diplomacy. Vol. 2, pp. 161-172.
- Fidler D. (2019) To Declare or Not to Declare: The Controversy over Declaring a Public Health Emergency of International Concern for the Ebola Outbreak in Congo. Asian Journal of WTO & International Health Law and Policy, vol. 14, pp. 287-330.
- Garrett L. (2020) Grim Reapers: How Trump and Xi set the Stage for the Coronavirus Pandemic. The New Republic. April 2.
- Gostin L., Katz R. (2016) The International Health Regulations: the governing framework for global health security. The Milbank Quarterly, vol. 2, pp. 264-313.
- Hamre D., Procknow J. (1966) A new virus isolated from the human respiratory tract. Proceedings of the Society for Experimental Biology and Medicine, vol. 121, pp. 190-193.
- Heath J. (2016) Global Emergency Power in the Age of Ebola. Harvard International Law Journal, vol. 57, pp. 1-47.
- Heymann D., Rodier G. (2004) SARS: a global response to an international threat. The Brown Journal of World Affairs, vol. 10, pp. 185-197.
- Hogan A., Jewell B., Sherrard-Smith E. et al. (2020) Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a model study. Lancet Global Health, no 9, pp. 1132-1141.
- Horton R. (2015) A plan to protect the world—and save WHO. The Lancet, vol. 103, p. 1.
- Huang C., Wang Y., Li X. et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, vol. 395, pp. 497-506.
- Kaslow D. et al. (2018) Vaccine candidates for poor nations are going to waste. Nature, vol. 564, pp. 337-339.
- Kelle A. (2007) Securitization of international public health: Implications for global health governance and the biological weapons prohibition regime. Global Governance: A Review of Multilateralism and International Organizations, vol. 2, pp. 217-235.
- Kremer M., Levin J., Snyder C. (2020) Advance Market Commitments: Insights from Theory and Experience. AEA Papers and Proceedings, vol. 110, pp. 269-273.
- Monchatre-Leroy E. et al. (2017) Identification of alpha and beta coronavirus in wildlife species in France: bats, rodents, rabbits, and hedgehogs. Viruses, vol. 9, pp. 1-12.
- Moon S., Sridhar D., Pate M. et al. (2015) Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. The Lancet, vol. 386, pp. 2204-2221.
- Morens D., Taubenberger J. (2018) The mother of all pandemics is 100 years old (and going strong). American journal of public health. Vol. 11, pp. 1449-1454.
- Morris L. (2020) German officials to discuss reported US attempt to buy exclusive rights to coronavirus vaccine. Washington Post. March 16.
- Mukherjee S. (2017) Emerging infectious diseases: Epidemiological perspective. Indian Journal of Dermatology, vol. 5, pp. 459-467.
- Pavone I. (2017) October, Ebola and Securitization of Health: UN Security Council Resolution 2177/2014 and its Limits. The Governance of Disease Outbreaks, pp. 301-326.
- Price S., Miazgowicz K., Munster V. (2014) The emergence of the Middle East Respiratory Syndrome coronavirus. Pathogens and Disease, no 2, pp. 121-136.
- Rappuoli R. et al. (2019) Vaccines and global health: In search of a sustainable model for vaccine development and delivery. Science Translational Medicine, June 2019, p. 19.
- Ratcliffe R., Standart M. (2020) China coronavirus: Mayor of Wuhan admits mistakes. The Guardian, no 76.
- Sedyaningsih E. et al. (2008) Towards mutual trust, transparency and equity in virus sharing mechanism: the avian influenza case of Indonesia. Ann Acad Med Singapore, vol. 29 pp. 482-488.
- Tyrrell D., Bynoe M. (1966) Cultivation of novel type of common-cold virus in organ cultures. British medical journal, vol. 1, pp. 1467-1470.
- Wang Y. et al. (2017) Ebola vaccines in clinical trial: the promising candidates. Human vaccines & immunotherapeutics, vol. 1, pp. 153-168.
- Wertheim J.et al. (2013) A case for the ancient origin of coronaviruses. Journal of Virology, vol. 12, pp. 7039-7045.
Supplementary files
